The final license will be revoked because GSK's licensed combination vaccine "Priorix-tetra" did not submit the review data in November 2013.

The vaccine is the first MMRV vaccine in Korea to have chickenpox prevention added to existing measles, rubella, and infectious mastitis. However it seems that GSK has not been able to actively respond to the cancellation as demand in Korea has decreased.

The MFDS ordered GSK's Priorix-tetra to be revoked on the 17th. It will take place as of June 1st.

This product is a live virus vaccine mixed with measles, mumps, rubella and chickenpox, and was approved by the MFDS in November 2013. In particular, it was comfortable because the exis